Infliximab
Concept
Vocabulary Service
Overview
subject area of
-
2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis Academic Article
-
A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease Academic Article
-
Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis Academic Article
-
Anti-TNFα therapy in immune-mediated subfertility: State of the art Academic Article
-
Anti-cytokine targeted therapies for ANCA-associated vasculitis Academic Article
-
Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitis Academic Article
-
Biologic survival. Academic Article
-
Canadian Association of Gastroenterology Clinical Practice Guidelines: The Use of Infliximab in Crohn's Disease Academic Article
-
Canadian cost-utility analysis of initiation and maintenance treatment with anti-TNF-α drugs for refractory Crohn's disease Academic Article
-
Changes in the gut microbiome associated with infliximab in patients with bipolar disorder Academic Article
-
Clinical Decision Support Tool for Infliximab in Crohn’s Disease Academic Article
-
Combination Therapy With Methotrexate in Inflammatory Bowel Disease: Time to COMMIT? Academic Article
-
Comparative Effectiveness of Biologics for Endoscopic Healing of the Ileum and Colon in Crohn's Disease Conference Paper
-
Comparative Efficacy and Rapidity of Action for Infliximab vs Ustekinumab in Biologic Naïve Crohn’s Disease Academic Article
-
Comparative Efficacy for Infliximab Vs Vedolizumab in Biologic Naive Ulcerative Colitis Academic Article
-
Comparative effectiveness of higher adalimumab maintenance therapy
versus
standard dose in anti‐tumor necrosis factor experienced Crohn's disease patients: A propensity‐score matched cohort analysis Academic Article
-
Comparative efficacy of golimumab, infliximab, and adalimumab for moderately to severely active ulcerative colitis: a network meta-analysis accounting for differences in trial designs Academic Article
-
Cost per remission and cost per response with infliximab, adalimumab, and golimumab for the treatment of moderately-to-severely active ulcerative colitis Academic Article
-
Does Smoking Reduce Infliximab’s Effectiveness against Crohn’s Disease? Academic Article
-
Editorial: methotrexate in patients with Crohn's disease refractory to anti-TNF therapy-moving backwards yet forward? Academic Article
-
Effect of Concomitant Therapy With Steroids and Tumor Necrosis Factor Antagonists for Induction of Remission in Patients With Crohn’s Disease: A Systematic Review and Pooled Meta-analysis Academic Article
-
Efficacy of Biological Therapies in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis Academic Article
-
End of Induction Patient-reported Outcomes Predict Clinical Remission but Not Endoscopic Remission in Crohn’s Disease Academic Article
-
Etanercept for patients with psoriasis who did not respond or who lost their response to adalimumab or infliximab Academic Article
-
Factors associated with changes in self-reported health status in infliximab-treated inflammatory bowel disease patients: results from a case management survey Academic Article
-
Higher adalimumab maintenance regimen is more effective than standard dose in anti-TNF experienced Crohn’s disease patients Academic Article
-
Hospitalization and surgical rates in patients with Crohn's disease treated with infliximab: a matched analysis Academic Article
-
Improvement of Lumbar Bone Mass after Infliximab Therapy in Crohn’s Disease Patients Academic Article
-
Incorporating Fecal Calprotectin Into Clinical Practice for Patients With Moderate-to-Severely Active Ulcerative Colitis Treated With Biologics or Small-Molecule Inhibitors Academic Article
-
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection Academic Article
-
Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report. Academic Article
-
Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis Academic Article
-
Infliximab-Induced Psoriasis and Psoriasiform Skin Lesions in Pediatric Crohn Disease and a Potential Association With IL-23 Receptor Polymorphisms Academic Article
-
Letter: comparative safety and efficacy of infliximab vs. adalimumab in Crohn's disease - should one consider disease location? Authors’ reply Academic Article
-
Lewis-Sumner syndrome associated with infliximab therapy in rheumatoid arthritis Academic Article
-
Meta-analysis: peri-operative anti-TNFα treatment and post-operative complications in patients with inflammatory bowel disease Academic Article
-
Nail Psoriasis and Biologics Academic Article
-
Occurrence of Plantar Pustular Psoriasis during Treatment with Infliximab Academic Article
-
Outcomes of Passable and Non-passable Strictures in Clinical Trials of Crohn’s Disease: A Post-hoc Analysis Academic Article
-
Patient outcomes after anti TNF-α drugs for Crohn’s disease Academic Article
-
Peripheral inflammatory biomarkers define biotypes of bipolar depression Academic Article
-
Practical Understanding of Mean Percent Psoriasis Area and Severity Index Reduction for Biologics Academic Article
-
Pragmatic pharmacoeconomic analyses by using post-market adverse drug reaction reports: an illustration using infliximab, adalimumab, and the Canada vigilance adverse reaction database Academic Article
-
Prevalence of endoscopic improvement and remission according to patient-reported outcomes in ulcerative colitis Academic Article
-
Refractory Primary Central Nervous System Vasculitis of Childhood: Successful Treatment with Infliximab Academic Article
-
Resource utilization during pediatric to adult transfer of care in IBD Academic Article
-
Review and Clinical Perspectives for the Use of Infliximab in Ulcerative Colitis Academic Article
-
Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel disease Academic Article
-
Review article: dose optimisation of infliximab for acute severe ulcerative colitis Academic Article
-
Systematic Review and Meta-Analysis: Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids Academic Article
-
The Effects of a Monoclonal Antibody Directed against Tumor Necrosis Factor-α in Asthma Academic Article
-
The Safety of Infliximab Infusions in the Community Setting Academic Article
-
The efficacy and safety of either infliximab or adalimumab in 362 patients with anti-TNF-α naïve Crohn's disease Academic Article
-
The incidence of inflammatory bowel disease in the pediatric population of Southwestern Ontario Academic Article
-
Treatment of Hospitalized Adult Patients With Severe Ulcerative Colitis: Toronto Consensus Statements Academic Article
-
Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease Academic Article